Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.45
Delayed Data
As of Mar 24
 +0.0155 / +3.57%
Today’s Change
0.13
Today|||52-Week Range
0.56
+217.12%
Year-to-Date

Today’s Trading

Previous close0.43
Today’s open0.44
Day’s range0.42 - 0.45
Volume2,248,744
Average volume (3 months)3,089,294
Market cap$106.8M
Dividend yield--
Data as of 4:02pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)-75.00%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.26

Competitors

 Today’s
change
Today’s
% change
--Innovative Pharmaceu...-0.00-1.35%
AFMDAffimed NV-0.15-5.77%
CORICorium International...-0.03-0.90%
CPIXCumberland Pharmaceu...+0.01+0.16%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$0.00
Annual profit (last year)-$9.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
Chief Financial Officer, Secretary &
Senior VP
Tae Heum Jeong
Corporate headquarters
Rockville, Maryland

Forecasts


Search for Jobs